Sara Ravaioli

1.4k total citations
54 papers, 939 citations indexed

About

Sara Ravaioli is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sara Ravaioli has authored 54 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Cancer Research and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sara Ravaioli's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Genomics and Diagnostics (9 papers). Sara Ravaioli is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (11 papers) and Cancer Genomics and Diagnostics (9 papers). Sara Ravaioli collaborates with scholars based in Italy, Switzerland and United States. Sara Ravaioli's co-authors include Sara Bravaccini, Maria Maddalena Tumedei, Maurizio Puccetti, Roberta Maltoni, Francesca Pirini, Emanuela Scarpi, Pierpaolo Pattacini, Rita Vacondio, Andrea Nitrosi and Valentina Iotti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Sara Ravaioli

51 papers receiving 927 citations

Peers

Sara Ravaioli

PRM

ONCOL

RNMI

Rachel L. Stewart United States

Leticia Varella United States

Merdol Ibrahim United Kingdom

Maud H. W. Starmans Netherlands

Philipp Jurmeister Germany

Soo‐Ryum Yang United States

Yul Ri Chung South Korea

Akshara Singareeka Raghavendra United States

Robert B. Jenkins United States

Gerald Li United States

Rachel L. Stewart United States

Sara Ravaioli

157 ×0.4

PRM

342 ×1.0

ONCOL

281 ×0.9

384 ×1.5

111 ×0.5

RNMI

Citations per year, relative to Sara Ravaioli Sara Ravaioli (= 1×) peers Rachel L. Stewart

Countries citing papers authored by Sara Ravaioli

Since Specialization

Citations

This map shows the geographic impact of Sara Ravaioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Ravaioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Ravaioli more than expected).

Fields of papers citing papers by Sara Ravaioli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Ravaioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Ravaioli. The network helps show where Sara Ravaioli may publish in the future.

Co-authorship network of co-authors of Sara Ravaioli

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Ravaioli. A scholar is included among the top collaborators of Sara Ravaioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Ravaioli. Sara Ravaioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cortesi, Michela, Sara Bravaccini, Sara Ravaioli, et al.. (2024). HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer. Cancers. 16(22). 3752–3752.

Barozzi, Iros, Neil Slaven, Rui Lopes, et al.. (2024). A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution. Cancer Discovery. 14(9). 1612–1630. 5 indexed citations

Bocchini, Martine, Marcella Tazzari, Sara Ravaioli, et al.. (2023). Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors. Frontiers in Oncology. 13. 1136331–1136331. 4 indexed citations

Cortesi, Michela, Michele Zanoni, Roberta Maltoni, et al.. (2022). TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer. Expert Opinion on Therapeutic Targets. 26(7). 593–602. 14 indexed citations

Cortesi, Michela, Michele Zanoni, Francesca Pirini, et al.. (2021). Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International Journal of Molecular Sciences. 23(1). 254–254. 45 indexed citations

Simeone, Pasquale, Stefano Tacconi, Serena Longo, et al.. (2021). Expanding Roles of De Novo Lipogenesis in Breast Cancer. International Journal of Environmental Research and Public Health. 18(7). 3575–3575. 36 indexed citations

Tumedei, Maria Maddalena, Sara Ravaioli, Federica Matteucci, et al.. (2021). Spotlight on PSMA as a new theranostic biomarker for bladder cancer. Scientific Reports. 11(1). 9777–9777. 5 indexed citations

Maltoni, Roberta, Sara Ravaioli, Giuseppe Bronte, et al.. (2021). Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?. Translational Oncology. 15(1). 101300–101300. 29 indexed citations

Fontana, Andrea, Raffaela Barbano, Elisa Dama, et al.. (2021). Combined analysis of miR-200 family and its significance for breast cancer. Scientific Reports. 11(1). 2980–2980. 32 indexed citations

10.

Bravaccini, Sara, Giuseppe Bronte, Elisabetta Petracci, et al.. (2021). The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects. Frontiers in Cell and Developmental Biology. 9. 772216–772216. 5 indexed citations

11.

Molinari, Chiara, Gianluca Tedaldi, Paolo Morgagni, et al.. (2020). Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis. Gastric Cancer. 24(2). 392–401. 7 indexed citations

12.

Liverani, Chiara, Alberto Bongiovanni, Laura Mercatali, et al.. (2020). 1170P The prognostic role of DLL3 expression in high-grade gastroenteropancreatic neuroendocrine neoplasms. Annals of Oncology. 31. S776–S776. 1 indexed citations

13.

Farolfi, Alberto, Elisabetta Petracci, Luigi Serra, et al.. (2020). Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ. Frontiers in Oncology. 10. 1486–1486. 12 indexed citations

14.

Iotti, Valentina, Paolo Giorgi Rossi, Andrea Nitrosi, et al.. (2019). Comparing two visualization protocols for tomosynthesis in screening: specificity and sensitivity of slabs versus planes plus slabs. European Radiology. 29(7). 3802–3811. 12 indexed citations

15.

Ravaioli, Sara. (2018). Cell-Free DNA Integrity: Applications. Methods in molecular biology. 1909. 77–83. 4 indexed citations

16.

Bravaccini, Sara, Maurizio Puccetti, Martine Bocchini, et al.. (2018). PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis. Scientific Reports. 8(1). 4254–4254. 133 indexed citations

17.

Casadio, Valentina, Samanta Salvi, Filippo Martignano, et al.. (2017). Cell-Free DNA Integrity Analysis in Urine Samples. Journal of Visualized Experiments. 14 indexed citations

18.

Iotti, Valentina, Sara Ravaioli, Rita Vacondio, et al.. (2017). Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging. Breast Cancer Research. 19(1). 106–106. 99 indexed citations

19.

Tumedei, Maria Maddalena, Rosella Silvestrini, Sara Ravaioli, et al.. (2015). Role of Androgen and Estrogen Receptors as Prognostic and Potential Predictive Markers of Ductal Carcinoma in Situ of the Breast. The International Journal of Biological Markers. 30(4). 425–428. 14 indexed citations

20.

Wandeler, Peter, Sara Ravaioli, & Thomas Bücher. (2007). Microsatellite DNA markers for the snow vole (Chionomys nivalis). Molecular Ecology Resources. 8(3). 637–639. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact